Related Experiment Video
Updated: Jun 8, 2026
07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Bortezomib in kidney transplantation
Rajeev Raghavan1, Abdallah Jeroudi, Katafan Achkar
1Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Journal of Transplantation
|October 19, 2010
Summary
Bortezomib, a proteasome inhibitor, shows potential for desensitizing transplant recipients and treating antibody-mediated rejection (AMR) by targeting antibody-producing plasma cells. Further clinical data is needed to confirm its efficacy in transplantation.
Area of Science:
- Immunology
- Nephrology
- Transplantation medicine
Background:
- Current therapies for pretransplant desensitization and antibody-mediated rejection (AMR) lack specific targeting of plasma cells responsible for anti-human leukocyte antigen (HLA) antibody production.
- Plasma cells are the primary producers of antibodies that can lead to transplant rejection.
Purpose of the Study:
- To review the existing literature on the use of bortezomib, a proteasome inhibitor, in organ transplantation.
- To evaluate the potential role of bortezomib in pretransplant desensitization and the treatment of AMR.
Main Methods:
- Literature review of studies investigating bortezomib in transplantation.
- Analysis of clinical data regarding bortezomib's effects on plasma cells and transplant outcomes.
Main Results:
- Bortezomib, used for multiple myeloma, induces apoptosis in plasma cells.
- Preliminary data suggests bortezomib may offer promise in desensitization and AMR treatment, but conflicting experiences also exist.
- Limited clinical experience necessitates further investigation.
Conclusions:
- Bortezomib's specific mechanism of action targets antibody-producing plasma cells, a key factor in AMR.
- The definitive role of bortezomib in transplantation protocols requires more extensive clinical data and trials.
- Further research is essential to establish bortezomib's efficacy and safety in managing antibody-mediated rejection and desensitization.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...